Preterm infants have significantly longer telomeres than their term born counterparts

Vimal Vasu1,2, Kara J Turner2, Shermi George1

  • 1Department of Child Health, East Kent Hospitals University Foundation NHS Trust, William Harvey Hospital, Ashford, Kent, United Kingdom.

Plos One
|June 29, 2017
PubMed

Insights

Preterm infants may not show accelerated biological aging by term-equivalent age, as telomere length, an aging biomarker, was shortest in term-born infants. Telomere attrition rate appears linked to gestational age.

Area of Science:

  • Neonatal Medicine
  • Genetics
  • Developmental Biology

Background:

  • Preterm birth is linked to established and emerging morbidities, including an 'aged' phenotype by term-equivalent age.
  • These morbidities, such as hypertension and insulin resistance, persist into adulthood, representing a public health concern.
  • Telomere length serves as a biomarker for biological aging.

Purpose of the Study:

  • To investigate if preterm infants exhibit accelerated biological aging by term-equivalent age.
  • To assess relative telomere length in leukocytes of preterm infants at birth and term-equivalent age.
  • To compare telomere length in preterm infants with term-born controls.

Main Methods:

  • Relative telomere length was measured in leukocytes from 25 preterm infants at term-equivalent age.
  • Measurements were compared with 22 preterm infants at birth and 31 term-born infants.
  • Longitudinal assessment of telomere attrition was performed on 5 preterm infants.

Main Results:

  • Relative telomere length was highly variable and negatively correlated with gestational age and birth weight in preterm infants.
  • Term-born infants had significantly shorter telomeres than both preterm groups.
  • Telomere lengths did not differ significantly between preterm infants at birth and term-equivalent age.
  • Telomere attrition rate was negatively correlated with increasing gestational age.

Conclusions:

  • Contrary to the hypothesis, preterm infants did not show shorter telomeres (indicating aging) by term-equivalent age compared to term-born controls.
  • Factors other than gestational age influence telomere length in preterm infants.
  • A declining preterm gestation may correlate with an increased telomere attrition rate.

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
27.7K
Telomeres and Telomerase02:41

Telomeres and Telomerase

7.6K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.5K
Replication in Eukaryotes02:31

Replication in Eukaryotes

Overview
206.4K
Replication in Eukaryotes01:29

Replication in Eukaryotes

In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
18.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K